Cosmos Health (COSM) EBT Margin (2014 - 2026)
Cosmos Health (COSM) recorded quarterly EBT Margin of 15.65% in Q1 2026, down 167.66% on a QoQ basis from 23.13% in Q4 2025, and down 968.0% year-over-year from 1.8% in Q1 2025.
Cosmos Health (COSM) EBT Margin (2014 - 2026) Analysis & Trends
Cosmos Health has disclosed EBT Margin across 12 years of filings, most recently posting 15.65% for Q1 2026.
- Quarterly EBT Margin fell 968.0% year-over-year to 15.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 357.24% (down 32898.0% YoY) and the FY2025 annual result came in at 1126.18%, down 109644.0% from the prior year.
- EBT Margin fell to 15.65% in Q1 2026, from 23.13% in the prior quarter.
- Over five years, EBT Margin peaked at 23.13% in Q4 2025 and troughed at 87.28% in Q4 2022.
- A 5-year average of 23.43% and a median of 15.65% in 2026 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 7845 bps — and 2025, when it soared 9022 bps.
- Tracing COSM's EBT Margin over 5 years: stood at 87.28% in 2022, then grew by 1 bps to 86.82% in 2023, then increased by 23 bps to 67.09% in 2024, then jumped by 134 bps to 23.13% in 2025, then sank by 168 bps to 15.65% in 2026.
- Business Quant data shows COSM's EBT Margin at 15.65% in Q1 2026, 23.13% in Q4 2025, and 31.28% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.21% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.67% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.64% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 4.45% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -2.59% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -50.18% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.23% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -15.65% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.65% |
| Dec 31, 2025 | 23.13% |
| Sep 30, 2025 | -31.28% |
| Jun 30, 2025 | -19.18% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -67.09% |
| Sep 30, 2024 | -17.59% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -12.80% |
| Dec 31, 2023 | -86.82% |
| Sep 30, 2023 | -26.63% |
| Jun 30, 2023 | -7.19% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | -87.28% |
| Sep 30, 2022 | -13.10% |
| Jun 30, 2022 | -9.33% |
| Mar 31, 2022 | 2.06% |
| Dec 31, 2021 | -8.82% |
| Sep 30, 2021 | -13.00% |
| Jun 30, 2021 | -14.57% |